253 related articles for article (PubMed ID: 35267615)
1. Transcending Blood-Opportunities for Alternate Liquid Biopsies in Oncology.
Werner B; Warton K; Ford CE
Cancers (Basel); 2022 Mar; 14(5):. PubMed ID: 35267615
[TBL] [Abstract][Full Text] [Related]
2. Non-blood sources of cell-free DNA for cancer molecular profiling in clinical pathology and oncology.
Ponti G; Manfredini M; Tomasi A
Crit Rev Oncol Hematol; 2019 Sep; 141():36-42. PubMed ID: 31212145
[TBL] [Abstract][Full Text] [Related]
3. The pitfalls and promise of liquid biopsies for diagnosing and treating solid tumors in children: a review.
Van Paemel R; Vlug R; De Preter K; Van Roy N; Speleman F; Willems L; Lammens T; Laureys G; Schleiermacher G; Tytgat GAM; Astrahantseff K; Deubzer H; De Wilde B
Eur J Pediatr; 2020 Feb; 179(2):191-202. PubMed ID: 31897843
[TBL] [Abstract][Full Text] [Related]
4. Targeted deep sequencing of cell-free DNA in serous body cavity fluids with malignant, suspicious, and benign cytology.
Yang SR; Mooney KL; Libiran P; Jones CD; Joshi R; Lau HD; Stehr H; Berry GJ; Zehnder JL; Long SR; Kong CS; Kunder CA
Cancer Cytopathol; 2020 Jan; 128(1):43-56. PubMed ID: 31751001
[TBL] [Abstract][Full Text] [Related]
5. ctDNA from body fluids is an adequate source for
Pérez-Barrios C; Sánchez-Herrero E; Garcia-Simón N; Barquín M; Clemente MB; Provencio M; Romero A
Clin Chem Lab Med; 2021 Jun; 59(7):1221-1229. PubMed ID: 33691348
[TBL] [Abstract][Full Text] [Related]
6. Circulating tumor DNA (ctDNA) application in investigation of cancer: Bench to bedside.
Alsaab HO; Alzahrani MS; Bahauddin AA; Almutairy B
Arch Biochem Biophys; 2024 Jun; 758():110066. PubMed ID: 38906310
[TBL] [Abstract][Full Text] [Related]
7. Liquid biopsy using the supernatant of a pleural effusion for EGFR genotyping in pulmonary adenocarcinoma patients: a comparison between cell-free DNA and extracellular vesicle-derived DNA.
Lee JS; Hur JY; Kim IA; Kim HJ; Choi CM; Lee JC; Kim WS; Lee KY
BMC Cancer; 2018 Dec; 18(1):1236. PubMed ID: 30526536
[TBL] [Abstract][Full Text] [Related]
8. Cell-Free DNA from Ascites and Pleural Effusions: Molecular Insights into Genomic Aberrations and Disease Biology.
Husain H; Nykin D; Bui N; Quan D; Gomez G; Woodward B; Venkatapathy S; Duttagupta R; Fung E; Lippman SM; Kurzrock R
Mol Cancer Ther; 2017 May; 16(5):948-955. PubMed ID: 28468865
[TBL] [Abstract][Full Text] [Related]
9. The Utility of Repetitive Cell-Free DNA in Cancer Liquid Biopsies.
Gezer U; Bronkhorst AJ; Holdenrieder S
Diagnostics (Basel); 2022 Jun; 12(6):. PubMed ID: 35741173
[TBL] [Abstract][Full Text] [Related]
10. Integrating liquid biopsies into the management of cancer.
Siravegna G; Marsoni S; Siena S; Bardelli A
Nat Rev Clin Oncol; 2017 Sep; 14(9):531-548. PubMed ID: 28252003
[TBL] [Abstract][Full Text] [Related]
11. Using circulating cell-free DNA to monitor personalized cancer therapy.
Oellerich M; Schütz E; Beck J; Kanzow P; Plowman PN; Weiss GJ; Walson PD
Crit Rev Clin Lab Sci; 2017 May; 54(3):205-218. PubMed ID: 28393575
[TBL] [Abstract][Full Text] [Related]
12. Liquid biopsy for children with central nervous system tumours: Clinical integration and technical considerations.
Stankunaite R; Marshall LV; Carceller F; Chesler L; Hubank M; George SL
Front Pediatr; 2022; 10():957944. PubMed ID: 36467471
[TBL] [Abstract][Full Text] [Related]
13. Liquid biopsy and PCR-free ultrasensitive detection systems in oncology (Review).
Finotti A; Allegretti M; Gasparello J; Giacomini P; Spandidos DA; Spoto G; Gambari R
Int J Oncol; 2018 Oct; 53(4):1395-1434. PubMed ID: 30085333
[TBL] [Abstract][Full Text] [Related]
14. Evaluating Pre-Analytical Variables for Saliva Cell-Free DNA Liquid Biopsy.
Salfer B; Havo D; Kuppinger S; Wong DTW; Li F; Zhang L
Diagnostics (Basel); 2023 May; 13(10):. PubMed ID: 37238150
[TBL] [Abstract][Full Text] [Related]
15. Liquid Biopsies from Pleural Effusions and Plasma from Patients with Malignant Pleural Mesothelioma: A Feasibility Study.
Moretti G; Aretini P; Lessi F; Mazzanti CM; Ak G; Metintaş M; Lando C; Filiberti RA; Lucchi M; Bonotti A; Foddis R; Cristaudo A; Bottari A; Apollo A; Del Re M; Danesi R; Mutti L; Gemignani F; Landi S
Cancers (Basel); 2021 May; 13(10):. PubMed ID: 34070018
[TBL] [Abstract][Full Text] [Related]
16. SiNVICT: ultra-sensitive detection of single nucleotide variants and indels in circulating tumour DNA.
Kockan C; Hach F; Sarrafi I; Bell RH; McConeghy B; Beja K; Haegert A; Wyatt AW; Volik SV; Chi KN; Collins CC; Sahinalp SC
Bioinformatics; 2017 Jan; 33(1):26-34. PubMed ID: 27531099
[TBL] [Abstract][Full Text] [Related]
17. Detection of Klebsiella pneumoniae cfDNA in pleural fluid and its clinical value.
Ren M; Li L; Chu M; Liu L
Ann Palliat Med; 2020 Sep; 9(5):3379-3384. PubMed ID: 32954758
[TBL] [Abstract][Full Text] [Related]
18. Differences in the genomic profiles of cell-free DNA between plasma, sputum, urine, and tumor tissue in advanced NSCLC.
Wu Z; Yang Z; Li CS; Zhao W; Liang ZX; Dai Y; Zhu Q; Miao KL; Cui DH; Chen LA
Cancer Med; 2019 Mar; 8(3):910-919. PubMed ID: 30767431
[TBL] [Abstract][Full Text] [Related]
19. The power of microRNAs as diagnostic and prognostic biomarkers in liquid biopsies.
Quirico L; Orso F
Cancer Drug Resist; 2020; 3(2):117-139. PubMed ID: 35582611
[TBL] [Abstract][Full Text] [Related]
20. Beyond the Blood: CSF-Derived cfDNA for Diagnosis and Characterization of CNS Tumors.
McEwen AE; Leary SES; Lockwood CM
Front Cell Dev Biol; 2020; 8():45. PubMed ID: 32133357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
